On the dot: A genetic-engineering approach to synthesizing a rationally designed recombinant peptide (termed rFC3) in Escherichia coli can be used for the solubilization of quantum dots (QDs). The rFC3 sequence contains only natural amino acids. Exchange of this peptide with CdSe–ZnS QDs coated with hydrophobic solvent allows surface recognition of the peptide (see picture).
No takes yet. Share an insight, caveat, or question.
Iyer et al. (2007) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: